Latest Governance News

Iondrive Limited has marked a pivotal shift from development to commercialisation of its IONSolv™ technology, securing $4 million to target the US e-waste market and commissioning its pilot plant to refine critical minerals.

Lightning Minerals has confirmed extensive gold and base metal mineralisation along a 12km strike at its Mt Turner Project, Queensland, following a successful inaugural drill program. The company secured A$2.5 million to fund an ambitious Phase 2 drilling campaign set for early 2026.

Australian United Investment Company Limited (AUI) has entered into a binding agreement to merge with Diversified United Investment Limited (DUI) through a share exchange scheme, aiming to enhance liquidity, reduce costs, and maintain dividends.

Sierra Nevada Gold (ASX – SNX) has won the bid for the expansive As Safra Copper-Gold Project in Saudi Arabia, marking a major step in its global exploration strategy. Concurrently, drilling progresses at its Nevada Warrior Gold Project with results anticipated soon.

Hexima Limited reports a stable cash position of $1.4 million for the December quarter while exploring strategic options including a potential capital return to shareholders.

Novatti Group has reported its December quarter results, marking a fourth consecutive EBITDA positive quarter in its Payments AU/NZ business and securing $1 million in strategic growth funding. The company’s stake in AUDC has nearly doubled following a successful Pre-Series A funding round.

Australian Strategic Materials reports a significant 75% jump in NdFeB alloy deliveries at its Korean Metals Plant and advances heavy rare earth production, while announcing a transformative acquisition offer from Energy Fuels Inc.

Atlas Arteria reported a 9.5% increase in toll revenue for Q4 2025, driven by steady traffic growth and strategic toll hikes across its global toll road portfolio.

Taiton Resources has completed drilling at its Challenger West project and is preparing to drill at the Highway project's Yogi prospect, backed by a $2 million capital raise and a key board appointment.

Amplia Therapeutics reports encouraging clinical progress for its pancreatic cancer drug narmafotinib, with a 35% confirmed response rate in the ACCENT trial and FDA support for dose optimisation. The company also uplisted to the US OTCQB market and secured a key patent extending protection to 2040.

Felix Gold has transitioned from exploration to development with a metallurgical breakthrough producing military-grade antimony and is advancing pilot plant operations and government funding applications to meet US military demand.

Lotus Resources reports steady progress at its Kayelekera uranium mine despite supply challenges, while its Letlhakane project shows promising metallurgical advances. The company targets full production and first shipments in the second quarter of 2026.